Salim Yusuf is a Professor of Medicine and Clinical Epidemiology and Biostatistics at McMaster University and Director of the Population Health Research Institute. As a Rhodes Scholar, he initiated the concept of large simple trials, coordinating the first ISIS trial and developing concepts of meta-analysis. Subsequently, he has applied these principles to several other areas that led to the SOLVD and DIG trials in heart failure while at the US NIH, and more recently the HOPE, OASIS, CURE and CREATE trials since his move to McMaster University, Canada. He holds a Heart and Stroke Foundation ...

University of Toronto

Stanley H Zlotkin, MD PhD FRCP(C) is a highly respected and celebrated leader in the field of medicine, and specifically childhood nutrition. His work, as a Professor of Paediatrics at the University of Toronto and a senior scientist and gastroenterologist/clinical nutritionist, has attracted worldwide attention for its innovation and impact. Most importantly has been his development and dissemination of innovative and easy-to-use nutritional supplements, such as iron and vitamins, to address deficiencies which affect many children in the developing world. He has been able to translate his ...

Dr. James Wright is a global leader in surgeryand has made important contributions to the care of Children. He was the first orthopedic surgeon to gain advanced clinical research training in north America and is a leader in applying evidence in orthopedics, which is transforming thecare of patients Worldwide. Nationally, his efforts have led to shortened surgical wait times for children. As Surgeon-in- Chief and Medical VP at Sickkids, one of the world's premier children's hospitals, his leadership has led to a culture of safety and innovation. He has received the highest research awards of ...

Dr. Whiteside is an MD and PhD graduate ofthe University of Toronto and FRCP(C) in Internal Medicine and Nephrology. From1985 to 2005 she was a staff nephrologist at the University Health Network,Toronto, and clinician-scientist in the Department of Medicine. From 2000 to2005 she was Associate Dean Graduate and Inter-Faculty Affairs in the Facultyof Medicine and from 2006 to 2014 Dean of Medicine and Vice Provost Relationswith Health Care Institutions at the University of Toronto. In 2012 she wasrecognized with WXN Canada's Most Powerful Women Top 100 Award.Dr. Whiteside was awarded in 2007 ...

Professor & Dir Autism Rsch, University of Alberta

Stollery Children's Hospital Foundation Chair in Autism. Renowned for work on Autism Spectrum Disorder (ASD). For 15 years he has co-led a multi-site longitudinal study of high-risk infants to characterize early development of ASD and co-developed the first observational scale to detect signs of ASD in infants which has been adopted internationally. National ASD Project Lead with NeuroDevNet, a Network of Centres of Excellence on neurodevelopmental disabilities; Director, Canadian Autism Research Training Program.

A Neurologist and Neuroscientist, Dr. Zochodne is the Director of the Division of Neurology and Co-Director of the Neurosciences and Mental Health Institute at the University of Alberta. He has devoted his career to understanding the biology and diseases of the peripheral nervous system, disorders that are common, disabling and frequently irreversible. He has been a leading investigator of diabetic polyneuropathy and nerve regeneration and he has served as Editor-in-Chief of the Canadian Journal of Neurological Science.  

Haibo Zhang, MD; PhD is Professor of Anesthesia, Medicine and Physiology at University of Toronto, and Staff Scientist in Keenan Research Centre for Biomedical Science of St. Michael's Hospital. His translational research program focuses on the mechanisms and therapy of acute lung injury, COVID-19 and sepsis. In the field of acute lung injury and ventilator-induced lung fibrosis, Dr. Zhang has been a driving force in determining the underlying cellular mechanisms and their application into clinical therapies, particularly with respect to host responses and the development of non-invasive ...

Professor and Head, Division of Gastroenterology, University of British Columbia; Head, Division of Gastroenterology, Vancouver General Hospital Dr. Eric Yoshida exemplifies the attributes required to be a leader and a key voice in discussions regarding ongoing health care delivery in Canada. Having been an integral component and the driving force behind the University of British Columbia's Hepatology Program, he has not only secured a reputable national profile for this department, but also, at the same time written numerous scholarly articles, and been an excellent mentor for the next ...

Faculty of Medicine Distinguished Research Chair, University of Ottawa

Dr. Phil Wells is a Hematologist. He is currently a University of Ottawa Distinguished Research Chair in Translational and AI Research in Venous Thrombosis. He is perhaps best known for pioneering the concept of clinical prediction rules: the "Wells Model for DVT" and the "Wells Model for PE" are taught and used world-wide. He has received over $30 million in peer reviewed research funding and has over 380 publications. His work has been acknowledged through a Canada Research Chair, and several lifetime achievement awards. His current interests are Cancer Associated Thrombosis and AI to ...

Professor, Western University

Charles Weijer is a leading expert on the ethics of randomized controlled trials. Publications on the duty of care in clinical research, the ethical analysis of study benefits and harms, and empowering communities in research have been broadly influential.From 2008 to 2013 Charles co-led a collaboration that produced the first international ethics guidelines for cluster randomized trials. From 2014 to 2018 he collaborated with Dr. Adrian M. Owen on a project exploring the ethics of functional neuroimaging after severe brain injury. Charles’ current work explores ethical issues in pragmatic ...